Extreme thrombocytosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors

MeSH terms

• Antineoplastic Agents / therapeutic use
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / blood*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
• Protein-Tyrosine Kinases / therapeutic use
• Severity of Illness Index
• Thrombocytosis / complications
• Thrombocytosis / diagnosis*
• Thrombocytosis / therapy
• Thrombosis / etiology